Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …

Background: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective,
breakthrough infections are occurring. Booster vaccinations have recently received emergency …

Heterologous dosing with the adenovirus-based ChAdOx1 (AstraZeneca) vaccine followed
by an mRNA vaccine induced stronger immune responses than did the homologous …

Emerging and re-emerging zoonotic viral diseases are major threats to global health, economic
stability, and national security. Vaccines are key for reducing coronaviral disease burden…

Accelerating Development of SARS-CoV-2 Vaccines Controlled human infection models
have been proposed as a strategy for accelerating SARS-CoV-2 vaccine development. But …

As part of a multicenter study evaluating homologous and heterologous COVID-19 booster
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …

While detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by
diagnostic reverse-transcription polymerase chain reaction (RT-PCR) is highly sensitive for viral …

… Correspondence and requests for reprints should be addressed to Meagan E. Deming, MD,
Ph.D., Department of Medicine, Institute of Human Virology, 725 West Lombard Street, N156…

Current seasonal influenza virus vaccines do not induce robust immune responses to
neuraminidase. Several factors, including immunodominance of hemagglutinin over …